Plant Health Care plc
("Plant Health Care" or "the Company")
Director Dealings / PDMR Shareholding
Plant Health Care, a leading provider of novel patent-protected biological products to global agriculturalmarkets,
has been informed that on 17 March 2022 Dr Christopher Richards, Chief Executive Officer of the Company, sold 695,446 ordinary shares of 1.0 pence each in the capital of the Company ("Ordinary Shares") at a price of 9.95 pence per Ordinary Share. This sale was made due to a clerical error by the administrator of Dr Richards's SIPP account and was only advised to Dr Richards last night. It is the intention of Dr Richards to purchase back these shares over the coming weeks.
Following this sale, Dr Richards and persons closely associated with him are beneficially interested in 3,675,527 Ordinary Shares, representing approximately 1.2% of the Company's issued share capital.
Enquiries
Plant Health Care plc |
+1 919 926 1600 |
Richard Webb - Chairman
|
|
|
|
Arden Partners plc - Nomad and Joint Broker John Llewellyn-Lloyd / Antonio Bossi
|
+44 (0)20 7614 5900 |
Cenkos Securities plc - Joint Broker Neil McDonald / Peter Lynch
|
+44 (0)20 7391 8900 |
Company website: www.planthealthcare.com
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||
a) |
Name |
Dr Christopher Richards |
||||||||
2 |
Reason for the notification |
|||||||||
a) |
Position/status |
Chief Executive Officer |
||||||||
b) |
Initial notification/Amendment |
Initial notification |
||||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
a) |
Name |
Plant Health Care plc |
||||||||
b) |
LEI |
213800KBQPJZ2FM8QH27
|
||||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary Shares of 1p each
|
||||||||
b) |
Nature of the transaction |
Sale of Shares |
||||||||
c) |
Price(s) and volume(s) |
|
||||||||
d) |
Aggregated information
|
N/A
|
||||||||
e) |
Date of the transaction |
17.03. 202 2 |
||||||||
f) |
Place of the transaction |
AIM, London Stock Exchange |